We offer specialized lab testing from a variety of nationally recognized laboratories to include testing for blood, urine, saliva and stool. This provides us with the best objective data to design an individualized treatment plan specifically for you. The following are some of the labs that we partner with:
Cell Since Systems – ALCAT Test
Clinical assessments of the Alcat Test used to guide dietary modification have shown significant improvement in many common symptoms. The Alcat Test may help uncover which foods and other substances trigger chronic inflammation and its related health issues such as gastrointestinal, metabolic disorders and others.
Medical laboratory, certified in the areas of clinical chemistry, bacteriology, mycology, parasitology, virology, microbiology, non-syphilis serology, general immunology, hematology, toxicology, as well as molecular genetics.
Spectracell a clinical laboratory company that specializes in preventing illness through comprehensive diagnostic health testing with a focus on micronutrient analysis, advanced cardiac risk, and generic testing.
Over the past 23 years, SpectraCell has become the foremost purveyor of nutritional deficiency testing. The developed a diagnostic methodology as a blood test for helping medical care providers assess micronutrients in terms of intracellular function.
The world's leading provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. Our services range from routine blood tests — such as total cholesterol, Pap testing and white blood cell count — to complex, gene-based and molecular testing.
Cleveland HeartLab Inc. offers reliable and affordable bio marker testing that enables physicians to better define patients at risk of heart disease and monitor therapeutic response.
Cleveland HeartLab offers innovative, scientifically proven, and medically relevant biomarkers that are predictive of cardiovascular risk. They offer inflammatory and other advanced biomarker testing that practitioners from across North America, Europe and Asia use in the management and prevention of heart disease. The novel biomarker technologies are offered through CAP-accredited and CLIA-certified clinical reference laboratory. The HearthLab also runs a research and development laboratory where next-generation cardiovascular disease biomarkers are being developed for use through our clinical laboratory. This valuable pipeline of tests is part of an exclusive intellectual property portfolio that targets large, under-addressed markets.